153 related articles for article (PubMed ID: 18280568)
1. Monomerization of dimeric IgG of intravenous immunoglobulin (IVIg) increases the antibody reactivity against intracellular antigens.
Wymann S; Ghielmetti M; Schaub A; Baumann MJ; Stadler BM; Bolli R; Miescher SM
Mol Immunol; 2008 May; 45(9):2621-8. PubMed ID: 18280568
[TBL] [Abstract][Full Text] [Related]
2. Self-reactivity in the dimeric intravenous immunoglobulin fraction.
Schaub A; Wymann S; Heller M; Ghielmetti M; Beleznay Z; Stadler BM; Bolli R; Miescher S
Ann N Y Acad Sci; 2007 Sep; 1110():681-93. PubMed ID: 17911483
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of antigen specificities in the monomeric and dimeric fractions of intravenous immunoglobulin.
Miescher SM; Schaub A; Ghielmetti M; Baumann M; Vogel M; Bolli R; Stadler B
Ann N Y Acad Sci; 2005 Jun; 1051():582-90. PubMed ID: 16126998
[TBL] [Abstract][Full Text] [Related]
4. Monomeric and dimeric IgG fractions show differential reactivity against pathogen-derived antigens.
Wymann S; Zuercher AW; Schaub A; Bolli R; Stadler BM; Miescher SM
Scand J Immunol; 2011 Jul; 74(1):31-41. PubMed ID: 21338382
[TBL] [Abstract][Full Text] [Related]
5. Identification of target antigens of self-reactive IgG in intravenous immunoglobulin preparations.
Bussone G; Dib H; Dimitrov JD; Camoin L; Broussard C; Tamas N; Guillevin L; Kaveri SV; Mouthon L
Proteomics; 2009 Apr; 9(8):2253-62. PubMed ID: 19296548
[TBL] [Abstract][Full Text] [Related]
6. Variable region-connected, dimeric fraction of intravenous immunoglobulin enriched in natural autoantibodies.
Vassilev TL; Bineva IL; Dietrich G; Kaveri SV; Kazatchkine MD
J Autoimmun; 1995 Jun; 8(3):405-13. PubMed ID: 7576001
[TBL] [Abstract][Full Text] [Related]
7. The autoreactivity of therapeutic intravenous immunoglobulin (IVIG) preparations depends on the fractionation methods used.
Djoumerska I; Tchorbanov A; Pashov A; Vassilev T
Scand J Immunol; 2005 Apr; 61(4):357-63. PubMed ID: 15853919
[TBL] [Abstract][Full Text] [Related]
8. Exposure of IgG to an acidic environment results in molecular modifications and in enhanced protective activity in sepsis.
Djoumerska-Alexieva IK; Dimitrov JD; Voynova EN; Lacroix-Desmazes S; Kaveri SV; Vassilev TL
FEBS J; 2010 Jul; 277(14):3039-50. PubMed ID: 20546303
[TBL] [Abstract][Full Text] [Related]
9. Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes.
Schaub A; von Gunten S; Vogel M; Wymann S; Rüegsegger M; Stadler BM; Spycher M; Simon HU; Miescher S
Allergy; 2011 Aug; 66(8):1030-7. PubMed ID: 21385183
[TBL] [Abstract][Full Text] [Related]
10. Characterization of immunoglobulin G fragments in liquid intravenous immunoglobulin products.
Diemel RV; ter Hart HG; Derksen GJ; Koenderman AH; Aalberse RC
Transfusion; 2005 Oct; 45(10):1601-9. PubMed ID: 16181211
[TBL] [Abstract][Full Text] [Related]
11. Chemically dimerized intravenous immunoglobulin has potent ameliorating activity in a mouse immune thrombocytopenic purpura model.
Machino Y; Suzuki E; Higurashi S; Ohta H; Suzuki M; Kohroki J; Masuho Y
Biochem Biophys Res Commun; 2012 Feb; 418(4):748-53. PubMed ID: 22306012
[TBL] [Abstract][Full Text] [Related]
12. Use of a human recombinant immunoglobulin G1 CH3 domain as a probe for detecting alternatively folded human IgG in intravenous Ig products.
Guhr T; Derksen N; Aalberse R; Rispens T
J Pharm Sci; 2012 Mar; 101(3):978-86. PubMed ID: 22102504
[TBL] [Abstract][Full Text] [Related]
13. L-Proline reduces IgG dimer content and enhances the stability of intravenous immunoglobulin (IVIG) solutions.
Bolli R; Woodtli K; Bärtschi M; Höfferer L; Lerch P
Biologicals; 2010 Jan; 38(1):150-7. PubMed ID: 19931468
[TBL] [Abstract][Full Text] [Related]
14. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
Szenczi A; Kardos J; Medgyesi GA; Závodszky P
Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
[TBL] [Abstract][Full Text] [Related]
15. A close look at human IgG sialylation and subclass distribution after lectin fractionation.
Stadlmann J; Weber A; Pabst M; Anderle H; Kunert R; Ehrlich HJ; Peter Schwarz H; Altmann F
Proteomics; 2009 Sep; 9(17):4143-53. PubMed ID: 19688751
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation.
MacMillan HF; Lee T; Issekutz AC
Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680
[TBL] [Abstract][Full Text] [Related]
17. Serum IgM, IgG and IgA block by F(ab')-dependent mechanism the binding of natural IgG autoantibodies from therapeutic immunoglobulin preparations to self-antigens.
Djoumerska IK; Tchorbanov AI; Donkova-Petrini VD; Pashov AD; Vassilev TL
Eur J Haematol; 2005 Feb; 74(2):101-10. PubMed ID: 15654899
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and immunological properties of four intravenous Immunoglobulin G preparations.
Redwan EL
Hum Antibodies; 2002; 11(3):79-84. PubMed ID: 12454368
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of two intravenous immunoglobulin. Preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients.
Lamari F; Karamanos NK; Papadopoulou-Alataki E; Kanakoudi-Tsakalidou F; Dimitracopoulos G; Anastassiou ED
J Pharm Biomed Anal; 2000 Jul; 22(6):1029-36. PubMed ID: 10857572
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay.
Hiemstra PS; Brands-Tajouiti J; van Furth R
J Lab Clin Med; 1994 Feb; 123(2):241-6. PubMed ID: 8301200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
